Antibiotic agents

Details Antibiotic agents Antibiotic agents

2005-08-16

2005-08-16

Peselev, Elli (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S007200

Reexamination Certificate

active

06930092

ABSTRACT:
Methods of treating a microbial infection comprising administering to a patient in need of such treatment are disclosed. In one aspect the method comprises administering to a patient in need of such treatment a therapeutically effective amount of Erythromycin B (or a pharmaceutically acceptable derivative thereof). In another aspect the method comprises a pharmaceutical composition comprising at least 50% by weight of Erythromycin B (or a pharmaceutically acceptable derivative thereof) of the total weight of antibiotic present in the composition. Also disclosed are 2′-esters of Erythromycin B and Erythromycin B enol ether.

REFERENCES:
patent: 2862921 (1958-12-01), Booth
patent: 3878192 (1975-04-01), Blasina et al.
patent: 0 553 353 (1993-08-01), None
patent: WO 98/33482 (1998-08-01), None
Martin et al, “Chemical modification of erythromycin antibiotics, 4. Structure-activity relations of erythromycin esters”, J. Med. Chem. 15(6):635-638 (1972).
Omura et al, “Research and development of clarithromycin”, Yakugaku Zasshi 112(9):593-614 (1992).
Jones et al, Chemical modifications of erythromycin antibiotics. 3. Synthesis of 4″ and 11 esters of erythromycin A and B, J. Med. Chem. 15(6):631-634 (1972).
Ono et al, “Drug resistance inStaphylococcus aureus. Induction of macrolide resistance by erythromycin, oleandomycin and their derivatives”, Jpn. J. Microbiol. 19(5):343-347 (1975).
Bojarska-Dahlig et al, “Quantitative structure-activity relationships in erythromycin group with MTD technique” , Pol. J. Pharmacol. Pharm. 33(3):359-363 (1981).
Kibwage et al, “Antibacterial Activities of Erythromycins A B C and D and Some of Their Derivatives”, Antimicrobial Agents and Chemotherapy 28(5):630-633 (1985).
Cane et al, “Macrolide biosynthesis, 3. Stereochemistry of the chain-elongation steps of erythromycin biosynthesis”, J. Am. Chem. Soc. 108(16):4957-4964 (1986.
Mordi et al, “Acid-Catalyzed Degradation of Clarithromycin and Erythromycin B: A Comparative Study Using NMR Spectroscopy”, J. Med. Chem. 43(3):467-474 (2000).
Bojarska-Dahlig, “Correlation of physiochemical parameters and antibacterial activity of macrocyclic antibiotics”, Abh. Akad. Wiss. DDR, Abt. Math. Naturwiss., Tech. (2N, Quant. Struct.-Act. Anal.), pp. 343-349 (1978).
Natl Coord Group Invest Short-Course Chemother: “Short Course Chemo Therapy in Pulmonary Tuberculosis”, Chin. J. Tuberc. Respir. Dis. 5(2):78-81 (1982).

Affiliated with

Also associated with

Rating

Antibiotic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibiotic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibiotic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3444599